DEFINITY not checked

Lantheus Medical Imaging

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Coronary Artery Disease, Heart Disease, Cardiac Disease
Main trialPhase 4
“The study is designed to see if stress echocardiography can be used as a screening exam in peri-, or post-menopausal women with a risk of developing of coronary artery disease and experiencing future cardiac events.”In the company’s words, NCT00162370 on ClinicalTrials.gov

Other drugs for Coronary Artery Disease

All 21 drugs for Coronary Artery Disease

Copies tested against it1

Other companies’ versions, mostly cheaper copies for when the patent ends

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 4Completed Sep 2012 A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease
Phase 3Completed 9 Jan 2020 DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow DEFINITY

Following is part of Solo: you see every change to DEFINITY the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in